Neurological & CognitiveStudiedIntl. Approved (Russia)

Semax

ACTH(4-10)-Pro-Gly-Pro · ACTH receptor partial agonism; upregulation of BDNF and NGF gene expression; modulation of dopaminergic, serotonergic, and cholinergic transmission; activation of melanocortin MC4R; inhibition of enkephalin degradation

Not medical advice. For educational and research reference only.

Typical Dose

200–600 mcg intranasally daily

Route

Intranasal

Cycle

2–4 week cycles (typical research protocol)

Storage

2–8°C Refrigerated

What is Semax?

Semax is a synthetic heptapeptide analog of the ACTH 4-7 fragment extended with Pro-Gly-Pro (PGP) to increase CNS stability and activity. Developed in Russia and approved there for stroke treatment, cognitive enhancement, and neuroprotection. Administered intranasally for direct CNS delivery. Robust Russian clinical literature; not FDA-approved in the US. Widely used as a research nootropic.

Mechanism of Action

ACTH receptor partial agonism; upregulation of BDNF and NGF gene expression; modulation of dopaminergic, serotonergic, and cholinergic transmission; activation of melanocortin MC4R; inhibition of enkephalin degradation

Target: ACTH receptor, BDNF/NGF pathways, melanocortin MC4R

Research Indications

Cognitive FunctionEffective

Research suggests improvements in memory, focus, and cognitive processing

NeuroprotectionModerate

May protect neurons from oxidative stress and inflammatory damage

Mood & AnxietyModerate

Some studies report anxiolytic and mood-stabilizing effects

Research Protocols

These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Starting DoseLow doseOnce dailyIntranasal or Injectable
Standard DoseStandardOnce dailyIntranasal or Injectable

Peptide & Drug Interactions

Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.

Stimulants (Modafinil, Adderall)Caution
MAOIs / SSRIsMonitor
RacetamsCaution
NAD+Compatible
BPC-157Compatible

How to Reconstitute & Inject

Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.

  1. 1

    Remove Semax vial from refrigeration and allow to reach room temperature (15–20 minutes)

  2. 2

    Clean vial top with alcohol swab and allow to air dry completely

  3. 3

    Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)

  4. 4

    Inject BAC water slowly down the side of the vial — do not aim directly at the powder

  5. 5

    Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide

  6. 6

    Allow 2–3 minutes for full dissolution — solution should be clear and colorless

  7. 7

    Draw calculated dose into an insulin syringe for subcutaneous injection

  8. 8

    Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy

  9. 9

    Store reconstituted solution refrigerated (2–8°C) and use within 28 days

What to Expect

Week 1–2

Subtle mood and focus improvements may begin. Sleep quality often improves early.

Week 2–4

Increased mental clarity, word recall, and reduced brain fog reported by many.

Week 4–8

Consistent cognitive improvements. Better stress response and working memory.

Week 8+

Sustained cognitive and neurological benefits. Effects may persist post-cycle.

Side Effects & Safety

  • Headache, particularly at initiation
  • Mild anxiety or restlessness with some compounds
  • Nasal irritation (intranasal administration)
  • Sleep disturbance if dosed too close to bedtime
  • Rare: Mood changes or emotional lability

FDA Status & Regulatory Info

Intl. Approved (Russia)

Semax is a synthetic heptapeptide analog of the ACTH 4-7 fragment extended with Pro-Gly-Pro (PGP) to increase CNS stability and activity. Developed in Russia and approved there for stroke treatment, cognitive enhancement, and neuroprotection. Administered intranasally for direct CNS delivery. Robust Russian clinical literature; not FDA-approved in the US. Widely used as a research nootropic.

Rx Required: No
503A Ban: No
Telehealth: N/A
Full FDA Status Tracker

Frequently Asked Questions

Research References

External links for education only. We do not control third-party content.

Community-reported data

The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.

Community Intelligence

What 73 users report

73 community reports

Positive 97% · Neutral 3% · Negative 0%

Most reported benefits

Mood
196
Cognition
196

Most reported side effects

Injection site irritation
5

Dose distribution

Median: 200–400 mcg · Most common: 200–400 mcg

0–25
0
25–50
0
50–100
0
100–200
37
200–400
71
400–600
40
600–1000
45
1000–2000
2
2000+
1

How repeat users are trending

Among repeat reporters, 92% said they felt similar to their last entry, 8% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 46 days · Based on 37 repeat reporters

Share Your Experience

Rate Semax in the PeptIQ app and help the community make informed decisions.

Research purposes only

This page is for educational reference. It is not medical or legal advice. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.